Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 1, 2024 | Horse | Paint | MSK | Swollen mouth; Swollen tongue; Tongue protrusion | Recovered/Normal |
| Jun 1, 2024 | Horse | Trakehner | MSK | Behavioural disorder NOS; Abnormal vision (see also impaired vision) | Outcome Unknown |
| Jun 1, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 1, 2024 | Horse | Horse (unknown) | MSK | Allergy NOS | Outcome Unknown |
| Jun 1, 2024 | Horse | Thoroughbred | MSK | Anorexia; Fever; Injection site pain; Injection site swelling | Recovered/Normal |
| May 31, 2024 | Horse | Pony (unspecified), Horse (... | MSK | Lack of efficacy - NOS; Intentional misuse | Recovered/Normal |
| May 31, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| May 31, 2024 | Horse | Pony of the Americas, Horse... | MSK | Lack of efficacy - NOS; Intentional misuse | Recovered/Normal |
| May 31, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 30, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 30, 2024 | Horse | Horse (other) | MSK | Diarrhoea | Ongoing |
| May 29, 2024 | Horse | Thoroughbred | MSK | Injection site swelling; Reluctant to move; Not eating | Recovered/Normal |
| May 29, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 29, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| May 28, 2024 | Horse | Horse (unknown) | MSK | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| May 28, 2024 | Horse | Thoroughbred | MSK | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Outcome Unknown |
| May 28, 2024 | Horse | Unknown | MSK | Hair modification NOS; Low weight gain | Outcome Unknown |
| May 28, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| May 27, 2024 | Horse | Haflinger | MSK | Application site swelling; Anorexia | Outcome Unknown |
| May 26, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| May 25, 2024 | Horse | Pony (unspecified) | MSK | Swollen muzzle; Ataxia | Outcome Unknown |
| May 25, 2024 | Horse | Horse (unknown) | MSK | Partial lack of efficacy | Recovered/Normal |
| May 23, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 23, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 23, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| May 23, 2024 | Horse | Hanovarian | MSK | Injection site swelling; Injection site pain; Swollen limb; Fever; Creased sk... | Ongoing |
| May 23, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| May 20, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 20, 2024 | Horse | Warmblood - Dutch, Hanovari... | MSK | Injection site pain; Injection site swelling | Recovered/Normal; Outcome Unknown |
| May 19, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| May 19, 2024 | Horse | Arab | MSK | Colic | Recovered/Normal |
| May 17, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 17, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 16, 2024 | Horse | Horse (unknown) | MSK | Oral swelling | Outcome Unknown |
| May 16, 2024 | Horse | Horse (unknown) | MSK | Injection site swelling | Outcome Unknown |
| May 16, 2024 | Horse | Arab | MSK | Abnormal oestrus NOS; Colic | Ongoing |
| May 15, 2024 | Horse | Unknown | MSK | Joint swelling | Outcome Unknown |
| May 15, 2024 | Horse | Horse (unknown) | MSK | Nystagmus; Tremor; Head bobbing | Recovered/Normal |
| May 14, 2024 | Horse | Paint | MSK | Lack of efficacy - NOS | Ongoing |
| May 14, 2024 | Horse | Crossbred Equine/horse, She... | MSK | Not himself/herself | Recovered/Normal |
| May 14, 2024 | Horse | Quarter Horse, Quarter Hors... | MSK | Lack of efficacy - NOS | Recovered/Normal |
| May 14, 2024 | Horse | Miniature | MSK | Fever; Tachycardia; Hyperventilation; Digestive tract hypermotility; Stress l... | Recovered/Normal |
| May 14, 2024 | Horse | Miniature | MSK | Fever; Tachycardia; Hyperventilation; Digestive tract hypermotility; Stress l... | Ongoing |
| May 13, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 13, 2024 | Horse | Haflinger, Quarter Horse, Q... | MSK | Lack of efficacy - NOS; Unrelated death | Recovered/Normal; Euthanized |
| May 11, 2024 | Horse | Horse (unknown) | MSK | Pruritus | Outcome Unknown |
| May 11, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 11, 2024 | Horse | Quarter Horse | MSK | Injection site swelling; Injection site warmth | Ongoing |
| May 10, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 10, 2024 | Horse | Horse (unknown) | MSK | Injection site swelling; Reluctant to move | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.